Ivabradine use in pregnant women—treatment indications and pregnancy outcome: an evaluation of the German Embryotox database

PURPOSE: Ivabradine has been approved for the treatment of chronic heart failure and chronic stable angina pectoris in Europe. Based on adverse outcomes of reproductive animal studies and the lack of human data, ivabradine is considered contraindicated during pregnancy. The aim of this observational...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoeltzenbein, Maria, Lehmann, Marie-Louise, Beck, Evelin, Dathe, Katarina, Schaefer, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Pharmacoepidemiology and Prescription
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184534/
https://www.ncbi.nlm.nih.gov/pubmed/33501507
http://dx.doi.org/10.1007/s00228-020-03066-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184534/
https://www.ncbi.nlm.nih.gov/pubmed/33501507
http://dx.doi.org/10.1007/s00228-020-03066-w

Ejemplares similares